ClinicalTrials.gg
CompletedNCT05767554Updated Aug 12, 2024

Depression, Experiential Diversity, and Behavioral Novelty

An interventional study of Brief modified behavioral activation in Depression, sponsored by University of Texas at Austin. Completed at 1 site in United States. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-12.

Sponsored by University of Texas at Austin · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
77
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

The purpose of the study is to test whether changes in behavioral patterns are related to changes in depression. Depression is a psychological condition that involves persistent sad mood and/or an inability to enjoy pleasurable activities. Very stable behavioral patterns may be related to symptoms of depression. The aim of this study is to learn more about the relationship between symptoms of depression and behavioral patterns that are collected via global positioning system location data from a smart phone.

02

Conditions studied

  • Depression

Browse trials for

Keywords

  • Behavioral activation
  • Mobile sensing
03

In context

Depression

8,240 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's enrollment of 77 is close to the median of 84 across 6,869 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

University of Texas at Austin is the lead sponsor of 326 studies on the registry; 79 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 5 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-25
  • Possession and daily use of a smart phone
  • Able to speak and read English
  • Patient Health Questionnaire -8 (PHQ-8) > 10
  • Behavioral Activation for Depression (BADS) Activation Subscale \< 16
  • Ability to complete all study procedures

Exclusion criteria

Exclusion Criteria:

  • Self-reported lifetime diagnosis of agoraphobia or bipolar disorder
  • Severe neurodevelopmental disorder
  • Major travel plans within study period
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
77 participants (actual)

Study arms

  • Experimental
    Brief modified behavioral activation

    Participants randomized to the behavioral activation condition will meet with a graduate level clinician for one hour.

    Behavioral: Brief modified behavioral activation

  • No intervention
    Measurement-only control

    Participants who are not randomized to the active condition will take part in a measurement-only control condition. They will participate in all portions of the study except for the in-person behavioral activation session. They will complete a baseline and fill out daily surveys.

Interventions

  • BehavioralBrief modified behavioral activation

    The clinician will deliver psychoeducation about the nature of depression and the rationale behind the behavioral activation model (i.e. increasing level of activation can begin a positive feedback cycle of reward and improvements in mood state). Participants will be encouraged to add new, enjoyable activities to their daily schedules. Clinicians will emphasize the importance of novelty and increased engagement with the surrounding environment in the psychoeducational portion and in activity scheduling.

06

What researchers measure

Primary outcomes

  1. Change in Patient Health Questionnaire-8 Total Score over 5 Weeks

    Level of depression symptoms assessed weekly by the Patient Health Questionnaire - 8 via smart phone survey. The PHQ-8 ranges from 0-24 with higher scores indicating more severe symptoms of depression.

    Time frame: Baseline and 5 weeks

Secondary outcomes

  1. Change in Behavioral Activation for Depression Scale over 5 Weeks

    Level of behavioral activation as measured by the Behavioral Activation for Depression Scale (BADS). The BADS ranges from 0-150 with higher scores indicating better functioning.

    Time frame: Baseline and 5 weeks

07

Study locations

1 site
  • University of Texas at Austin Institute of Mental Health Research
    Austin, Texas 78712, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05767554
Responsible party
Christopher G. Beevers (Professor of Psychology, University of Texas at Austin) — Principal investigator
First posted
Mar 14, 2023
Start date
Apr 21, 2023
Primary completion
Mar 31, 2024
Completion
Mar 31, 2024
Last update
Aug 12, 2024

Study contacts

Christopher G Beevers, PhD
principal investigator · University of Texas at Austin

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion